Research never stops

Top Story

Evotec extends integrated drug discovery alliance with Genentech

Hamburg, Germany, 24 May 2016: Evotec AG today announced that Genentech, a member of the Roche Group, has extended its integrated drug discovery alliance with Evotec for a further three years to discover novel small molecule therapeutics.

- read more

Evotec AG reports results of first quarter 2016

Hamburg, Germany, 10 May 2016: Evotec AG today reported financial results and corporate updates for the first quarter of 2016.

- read more

Evotec and ex scientia announce partnership to discover bispecific small molecule immuno-oncology therapeutics

Hamburg, Germany, Dundee, UK - 26 April 2016: Evotec AG and ex scientia Ltd (Dundee, UK) today announced a collaboration with the objective to discover and develop first-in-class bispecific small molecule immuno-oncology therapies.

- read more
loading weather report
Loading weather report...


Jun 06, 2016 - BIO International Convention

Jun 07, 2016 - Jefferies 2016 Healthcare Conference

Company Presentation May

Building integrated and high-value drug discovery alliances
2016-05_Evotec_Company presentation_May